1. Field of the Invention
The present invention relates generally to alarm systems for patient physiological data monitoring instruments. In particular, the present invention relates to an alarm escalation system including mechanisms for indicating a level of criticality of alarms corresponding to physiological measurements and equipment status indicators of patient monitoring devices.
2. Description of the Related Art
This section is intended to introduce the reader to various aspects of art that may be related to various aspects of the present invention, which are described and/or claimed below. This discussion is believed to be helpful in providing the reader with background information to facilitate a better understanding of the various aspects of the present invention. Accordingly, it should be understood that these statements are to be read in this light, and not as admissions of prior art.
Patient monitors include medical devices that facilitate observation of patient physiological data. For example, a typical patient monitor detects and displays a patient's vital signs continually. This improves patient care by facilitating continuous supervision of a patient without continuous attendance by a human observer (e.g., a nurse or physician). Typically, patient monitors include alarm systems that provide audible and/or visual indications of certain predefined conditions. For example, some patient monitors include alarms that are triggered based on physiological conditions (e.g., high and low patient heart rate thresholds, arterial oxyhemoglobin saturation) or status indicators for the monitor itself (e.g., power loss). These alarms further facilitate supervision of patients and improve patient care by providing caregivers with warnings concerning certain monitored conditions. Generally, such alarms remain in an alarm state until acknowledged by a user. For example, an audible alarm for a patient's abnormal systolic condition may continue to sound until a user presses an acknowledge button that silences the alarm and indicates that the alarm has been recognized. Such audible alarms for patient monitors generally incorporate unchanging alarm tones or auditory effects. It is now recognized that such unchanging alarms tend to cause patient monitor users/operators (e.g., nurses, physicians, and caregivers) to become desensitized to ongoing and unacknowledged audible alarms.
Advantages of the invention may become apparent upon reading the following detailed description and upon reference to the drawings in which:
One or more specific embodiments of the present invention will be described below. In an effort to provide a concise description of these embodiments, not all features of an actual implementation are described in the specification. It should be appreciated that in the development of any such actual implementation, as in any engineering or design project, numerous implementation-specific decisions must be made to achieve the developers' specific goals, such as compliance with system-related and business-related constraints, which may vary from one implementation to another. Moreover, it should be appreciated that such a development effort might be complex and time consuming, but would nevertheless be a routine undertaking of design, fabrication, and manufacture for those of ordinary skill having the benefit of this disclosure.
In some embodiments, spatial separation of the first speaker 12 and the second speaker 14 may be used to increase alarm awareness among caregivers and to ensure that all areas of a room are accessible to an alarm. For example, stereo characteristics and so forth may be utilized to get the attention of a caregiver that is desensitized to typical alarms. In a specific example, the spatial separation of the first speaker 12 and second speaker 14 may be used to create unique sounds and/or to improve sound projection to all areas of a room. Further, embodiments of the present invention may be engineered to ensure that the location of the alarm device emitting the alarm is apparent to the caregiver. For example, if multiple devices are in a room, certain sound effects may be utilized to direct a caregiver's attention to the specific device that is emitting an alarm.
Alarm conditions are designated on the pulse oximeter 10 using set points or by designating patterns of values (e.g., patterns in an SpO2 trend) that can be entered via adjustment buttons 18. For example, a user can input a certain set point (e.g., 103 degrees Fahrenheit, blood oxygen level of 97%) that creates an alarm condition when crossed by actual patient data (e.g., actual patient temperature, actual blood oxygen level), or when processed values or patterns of values are detected. The pulse oximeter 10 may detect alarm conditions using an alarm detection device that compares designated set points with actual patient data received from a sensor 20 via a cable connection port 22 that is configured to communicatively couple with the sensor 20. For example, in some embodiments, the alarm detection device employs SatSeconds™ by Nellcor™ to detect alarms and manage nuisance alarms. SatSeconds™ may include alarming based on an integral of time and depth of a desaturation event. The sensor 20 may be defined as an accessory used to collect and send patient data to the pulse oximeter 10. One end of the sensor 20 is typically coupled to a patient (e.g., to a patient's finger, toe, ear lobe, or forehead) and the other end couples either directly or indirectly (e.g., via a separate monitor cable) to the pulse oximeter 10. Exemplary sensors may include sensors available from Nellcor Puritan Bennett Incorporated. The sensor 20 in the illustrated embodiment couples with a patient's finger and is configured to collect patient physiological data by sensing a patient's pulse rate and percentage of oxygen in the arterial blood. Once collected, these measurements are sent to the pulse oximeter 10.
As set forth above, the pulse oximeter 10 illustrated by
Incorporating a plurality of speakers (e.g., speaker 12 and 14) with the pulse oximeter 10 provides versatility, redundancy, and reliability. For example, by emitting alarm tones and alarm reminder tones from multiple speakers, embodiments of the present invention can produce unique and recognizable alarm sounds that attract the attention of users by elevating annoyance levels of the alarm sounds. This versatility can increase the awareness of caregivers that may not respond quickly to standard alarms, resulting in improved response times and so forth. In a specific example, an alarm may sound from speaker 12 based on a blood pressure reading that passes a predefined alarm threshold. If this alarm is not acknowledged by, for example, pressing the alarm silence button 16, speaker 14 emits a secondary alarm having a different tone than the first alarm to further alert the caregiver of the alarm condition.
In addition to providing auditory versatility, having multiple speakers creates redundancy that improves reliability in the event of a speaker failure (e.g., a speaker being blocked and muffled by an object or a speaker with a faulty connection). Not all unacknowledged alarms will necessarily result from caregivers failing to hear or recognize the initial alarm. Indeed, an initial alarm may remain unacknowledged because a speaker assigned the task of emitting the initial alarm either failed to produce or failed to adequately emit the initial alarm tone. For example, if speaker 12 is configured to emit an initial alarm tone and speaker 14 is configured to emit a reminder alarm tone after the initial alarm is unacknowledged for a designated period, the reminder alarm tone provided by speaker 14 will serve as a back up alarm to alert the user of a pending alarm condition in the event speaker 12 fails to provide the initial alarm tone.
In another embodiment, both speakers 12 and 14 are essentially completely redundant. For example, in a completely redundant embodiment, all speakers (e.g., 12 and 14) are configured to emit the same alarm tones and alarm reminder tones based on the same measured conditions and unacknowledged alarms. If one speaker fails, at least one other speaker will have been redundantly assigned the same alarming task.
It should be noted that, in some embodiments, alarms are visually and/or haptically indicated in addition to being audibly indicated. Indeed, alarms may be indicated to alert any of a caregiver's senses (e.g., sight, touch, and hearing). These alternative sensory indications (e.g., alarm lights and vibrating pagers) are additional tools with which a user's attention can be directed to an alarm condition. For example, the pulse oximeter 10 includes a display 24, such as a liquid crystal display (LCD), that visibly displays alarm indications and other information. In one embodiment, the display 24 is configured to visually communicate patient physiological data (e.g., oxygen saturation percentage, pulse amplitude, pulse rate) and alarms in the form of numeric data, textual data, and/or graphical data (e.g., plethysmographic waveforms and/or alarm icons). The display 24 may also be configured to display equipment status indicators such as an on/off indication depending on whether a power button 26 in latched or unlatched, a power indication depending on whether a power cord 28 is receiving power, and/or other equipment status indicators. In one embodiment, the display 24 is used to visually confirm values entered while configuring aspects of the pulse oximeter 10 (e.g., providing set points for alarms via the adjustment buttons 18). It should also be noted that these extra indications provide supplemental redundancy.
After an alarm has been initiated (block 46), the method 40 begins determining whether the alarm condition still exists and/or whether the alarm signal has been acknowledged, as illustrated by blocks 50 and 52. Specifically, block 50 is a decision block regarding whether a user has provided confirmation that the alarm condition has been recognized or acknowledged. Such an indication of acknowledgement may be provided by, for example, depressing the alarm silence button 16. If the alarm condition has been acknowledged, the unexpired alarm timer is reset or canceled (block 54) and an alarm silence timer may be initiated (block 56). In the illustrated embodiment, the alarm silence timer is then monitored, as illustrated by block 58. When the alarm silence timer expires, block 58 directs the method 40 to start again at block 42. In some embodiments, the alarm silence timer is not utilized. For example, in some embodiments, once a specific alarm is acknowledged, the same alarm condition will not initiate the primary alarm again, thus eliminating potentially unnecessary alarms. In other words, in such embodiments, the same alarm condition will not cause repeated alarm signals to be periodically emitted after acknowledgement when the alarm silence timer expires.
Block 52 is a decision block regarding whether the alarm condition still exists after being initiated. If the alarm condition is no longer present (e.g., the patient's blood pressure returns to normal), the alarm signal is canceled in block 60, the alarm timer is reset or canceled in block 62, and the method 40 begins again at block 42. For example, in one embodiment, if a patient's temperature passes a set point and then returns to normal the alarm will cease regardless of whether the alarm has been acknowledged. If the alarm condition remains present and has not been acknowledged, the alarm signal is continually emitted, the alarm timer continues to run, and the method 40 proceeds to block 64. It should be noted that in some embodiments, the presence of the alarm condition is not required to maintain the alarm. In other words, the method 40 proceeds without determining whether the alarm condition persists (block 52). For example, in some embodiments, the alarm remains active until acknowledged regardless of whether the alarm condition ceases to exist. This may be desirable in situations that benefit from requiring a user to be made aware that an alarm event occurred.
Block 64 is a decision block regarding whether the alarm timer has expired. If the alarm timer has not expired, the method 40 loops back to block 50. If the alarm timer has expired, a secondary alarm signal is emitted (block 66). As discussed above, this secondary alarm not only serves to increase awareness but also provides redundancy. In one embodiment, the secondary alarm signal has properties different than the primary alarm. For example, where the primary alarm is an audible tone, the secondary alarm may be an audible tone that is emitted with a higher frequency and/or a higher volume. Additionally, if the alarm timer has expired, the alarm timer may be reset with different properties (block 68). For example, the alarm timer may be reset with a reduced period (e.g., half of the initial alarm timer period). In some embodiments, this procedure continues as each successive alarm timer expires, thus gradually increasing communicated urgency, distinguishing features (e.g., type of sound), and/or the annoyance level of the alarm. Further, it should be noted that in some embodiments, acknowledging the alarm by, for example, pushing the alarm silence button 16, acknowledges and silences all alarms (e.g., both primary and secondary alarms).
As shown in
Each of the patient monitors 92 includes a sensing device 102 (e.g., temperature sensor, pulse sensor) for measuring patient physiological data. Additionally, each of the monitors 92 or the central management station 94 is configured to alarm based on predefined physiological data values or conditions relating to such values. For example, an alarm may be activated when a patient's temperature has been at a certain level for a predefined amount of time.
When alarm conditions are detected, the system 90 emits alarm signals from the audible alarm system 96 and/or the alarm paging system 98. Further, as discussed above, if the alarm is not acknowledged, the monitoring system 90 increases the alarm annoyance level. For example, in the illustrated embodiment, a primary alarm signal is sent to a first pager 100A. If this primary alarm is not acknowledged within a predefined amount of time, a second alarm is sent to a second pager 100B. If the second alarm remains unacknowledged for a predefined amount of time (e.g., half of the time allotted to acknowledge the primary alarm), a third alarm is sent to a third pager 100C and so forth. Additionally, the annoyance level of each pager alarm may be increased. For example, the pagers may beep or vibrate with a higher amplitude and/or frequency. Further, audible alarms from a speaker or speakers of the audible alarm system 96 may substitute or supplement the pager alarms. Indeed, the audible alarm system 96 may emit audible alarm tones with increasingly annoying characteristics, as discussed above with regard to
While the invention may be susceptible to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and will be described in detail herein. However, it should be understood that the invention is not intended to be limited to the particular forms disclosed. Rather, the invention is to cover all modifications, equivalents and alternatives falling within the spirit and scope of the invention as defined by the following appended claims.
This application is a continuation of U.S. application Ser. No. 11/241,513 filed Sep. 30, 2005, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3638640 | Shaw | Feb 1972 | A |
4714341 | Hamaguri et al. | Dec 1987 | A |
4805623 | Jöbsis | Feb 1989 | A |
4807631 | Hersh et al. | Feb 1989 | A |
4911167 | Corenman et al. | Mar 1990 | A |
4913150 | Cheung et al. | Apr 1990 | A |
4936679 | Mersch | Jun 1990 | A |
4938218 | Goodman et al. | Jul 1990 | A |
4971062 | Hasebe et al. | Nov 1990 | A |
4972331 | Chance | Nov 1990 | A |
4974591 | Awazu et al. | Dec 1990 | A |
5028787 | Rosenthal et al. | Jul 1991 | A |
5065749 | Hasebe et al. | Nov 1991 | A |
5084327 | Stengel | Jan 1992 | A |
5119815 | Chance | Jun 1992 | A |
5122974 | Chance | Jun 1992 | A |
5167230 | Chance | Dec 1992 | A |
5190038 | Polson et al. | Mar 1993 | A |
5246003 | DeLonzor | Sep 1993 | A |
5247931 | Norwood | Sep 1993 | A |
5263244 | Centa et al. | Nov 1993 | A |
5275159 | Griebel | Jan 1994 | A |
5279295 | Martens et al. | Jan 1994 | A |
5297548 | Pologe | Mar 1994 | A |
5355880 | Thomas et al. | Oct 1994 | A |
5372136 | Steuer et al. | Dec 1994 | A |
5385143 | Aoyagi | Jan 1995 | A |
5390670 | Centa et al. | Feb 1995 | A |
5413099 | Schmidt et al. | May 1995 | A |
5469845 | DeLonzor et al. | Nov 1995 | A |
5482036 | Diab et al. | Jan 1996 | A |
5483646 | Uchikoga | Jan 1996 | A |
5553614 | Chance | Sep 1996 | A |
5564417 | Chance | Oct 1996 | A |
5575285 | Takanashi et al. | Nov 1996 | A |
5611337 | Bukta | Mar 1997 | A |
5630413 | Thomas et al. | May 1997 | A |
5645059 | Fein et al. | Jul 1997 | A |
5645060 | Yorkey | Jul 1997 | A |
5652566 | Lambert | Jul 1997 | A |
5680857 | Pelikan et al. | Oct 1997 | A |
5692503 | Kuenstner | Dec 1997 | A |
5730124 | Yamauchi | Mar 1998 | A |
5730140 | Fitch | Mar 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5779631 | Chance | Jul 1998 | A |
5782757 | Diab et al. | Jul 1998 | A |
5786592 | Hök | Jul 1998 | A |
5830136 | DeLonzor et al. | Nov 1998 | A |
5830139 | Abreu | Nov 1998 | A |
5831598 | Kauffert et al. | Nov 1998 | A |
5842981 | Larsen et al. | Dec 1998 | A |
5871442 | Madarasz et al. | Feb 1999 | A |
5873821 | Chance et al. | Feb 1999 | A |
5920263 | Huttenhoff et al. | Jul 1999 | A |
5995855 | Kiani et al. | Nov 1999 | A |
5995856 | Mannheimer et al. | Nov 1999 | A |
5995859 | Takahashi | Nov 1999 | A |
6011986 | Diab et al. | Jan 2000 | A |
6027453 | Miwa et al. | Feb 2000 | A |
6027455 | Inukai et al. | Feb 2000 | A |
6036651 | Inukai et al. | Mar 2000 | A |
6036652 | Inukai et al. | Mar 2000 | A |
6064898 | Aldrich | May 2000 | A |
6081742 | Amano et al. | Jun 2000 | A |
6088607 | Diab et al. | Jul 2000 | A |
6120460 | Abreu | Sep 2000 | A |
6134460 | Chance | Oct 2000 | A |
6150951 | Olejniczak | Nov 2000 | A |
6154667 | Miura et al. | Nov 2000 | A |
6163715 | Larsen et al. | Dec 2000 | A |
6181958 | Steuer et al. | Jan 2001 | B1 |
6181959 | Schöllermann et al. | Jan 2001 | B1 |
6230035 | Aoyagi et al. | May 2001 | B1 |
6266546 | Steuer et al. | Jul 2001 | B1 |
6285895 | Ristolainen et al. | Sep 2001 | B1 |
6312393 | Abreu | Nov 2001 | B1 |
6353750 | Kimura et al. | Mar 2002 | B1 |
6397091 | Diab et al. | May 2002 | B2 |
6398727 | Bui et al. | Jun 2002 | B1 |
6415236 | Kobayashi et al. | Jul 2002 | B2 |
6419671 | Lemberg | Jul 2002 | B1 |
6438399 | Kurth | Aug 2002 | B1 |
6461305 | Schnall | Oct 2002 | B1 |
6466809 | Riley | Oct 2002 | B1 |
6487439 | Skladnev et al. | Nov 2002 | B1 |
6501974 | Huiku | Dec 2002 | B2 |
6501975 | Diab et al. | Dec 2002 | B2 |
6526301 | Larsen et al. | Feb 2003 | B2 |
6527725 | Inukai et al. | Mar 2003 | B1 |
6544193 | Abreu | Apr 2003 | B2 |
6546267 | Sugiura et al. | Apr 2003 | B1 |
6549795 | Chance | Apr 2003 | B1 |
6579242 | Bui et al. | Jun 2003 | B2 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6591122 | Schmitt | Jul 2003 | B2 |
6594513 | Jobsis et al. | Jul 2003 | B1 |
6606509 | Schmitt | Aug 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6615064 | Aldrich | Sep 2003 | B1 |
6618042 | Powell | Sep 2003 | B1 |
6622095 | Kobayashi et al. | Sep 2003 | B2 |
6654621 | Palatnik et al. | Nov 2003 | B2 |
6654624 | Diab et al. | Nov 2003 | B2 |
6658276 | Kianl et al. | Dec 2003 | B2 |
6658277 | Wasserman | Dec 2003 | B2 |
6662030 | Khalil et al. | Dec 2003 | B2 |
6668183 | Hicks et al. | Dec 2003 | B2 |
6671526 | Aoyagi et al. | Dec 2003 | B1 |
6671528 | Steuer et al. | Dec 2003 | B2 |
6678543 | Diab et al. | Jan 2004 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
6690958 | Walker et al. | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
6708048 | Chance | Mar 2004 | B1 |
6711424 | Fine et al. | Mar 2004 | B1 |
6711425 | Reuss | Mar 2004 | B1 |
6714245 | Ono | Mar 2004 | B1 |
6731274 | Powell | May 2004 | B2 |
6785568 | Chance | Aug 2004 | B2 |
6793654 | Lemberg | Sep 2004 | B2 |
6801797 | Mannheimer et al. | Oct 2004 | B2 |
6801798 | Geddes et al. | Oct 2004 | B2 |
6801799 | Mendelson | Oct 2004 | B2 |
6816266 | Varshneya et al. | Nov 2004 | B2 |
6829496 | Nagai et al. | Dec 2004 | B2 |
6830549 | Bui et al. | Dec 2004 | B2 |
6850053 | Daalmans et al. | Feb 2005 | B2 |
6863652 | Huang et al. | Mar 2005 | B2 |
6873865 | Steuer et al. | Mar 2005 | B2 |
6889153 | Dietiker | May 2005 | B2 |
6898451 | Wuori | May 2005 | B2 |
6939307 | Dunlop | Sep 2005 | B1 |
6947780 | Scharf | Sep 2005 | B2 |
6949081 | Chance | Sep 2005 | B1 |
6961598 | Diab | Nov 2005 | B2 |
6979812 | Al-Ali | Dec 2005 | B2 |
6983178 | Fine et al. | Jan 2006 | B2 |
6993371 | Kiani et al. | Jan 2006 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
7006865 | Cohen et al. | Feb 2006 | B1 |
7024235 | Melker et al. | Apr 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
7030749 | Al-Ali | Apr 2006 | B2 |
7035697 | Brown | Apr 2006 | B1 |
7047056 | Hannula et al. | May 2006 | B2 |
7079036 | Cooper et al. | Jul 2006 | B2 |
7107096 | Fischell et al. | Sep 2006 | B2 |
7123950 | Mannheimer | Oct 2006 | B2 |
7127278 | Melker et al. | Oct 2006 | B2 |
7162306 | Caby et al. | Jan 2007 | B2 |
7173525 | Albert | Feb 2007 | B2 |
7186966 | Al-Ali | Mar 2007 | B2 |
7209775 | Bae et al. | Apr 2007 | B2 |
7222054 | Geva | May 2007 | B2 |
7236811 | Schmitt | Jun 2007 | B2 |
7263395 | Chan et al. | Aug 2007 | B2 |
7272426 | Schmid | Sep 2007 | B2 |
7292141 | Staats et al. | Nov 2007 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
20010005773 | Larsen et al. | Jun 2001 | A1 |
20010020122 | Steuer et al. | Sep 2001 | A1 |
20010039376 | Steuer et al. | Nov 2001 | A1 |
20010044700 | Kobayashi et al. | Nov 2001 | A1 |
20010045509 | Al-Ali | Nov 2001 | A1 |
20020026106 | Khalil et al. | Feb 2002 | A1 |
20020035318 | Mannheimer et al. | Mar 2002 | A1 |
20020038079 | Steuer et al. | Mar 2002 | A1 |
20020042558 | Mendelson | Apr 2002 | A1 |
20020049389 | Abreu | Apr 2002 | A1 |
20020062071 | Diab et al. | May 2002 | A1 |
20020111748 | Kobayashi et al. | Aug 2002 | A1 |
20020133068 | Huiku | Sep 2002 | A1 |
20020156354 | Larson | Oct 2002 | A1 |
20020161287 | Schmitt | Oct 2002 | A1 |
20020161290 | Chance | Oct 2002 | A1 |
20020165439 | Schmitt | Nov 2002 | A1 |
20020198443 | Ting | Dec 2002 | A1 |
20030023140 | Chance | Jan 2003 | A1 |
20030055324 | Wasserman | Mar 2003 | A1 |
20030060693 | Monfre et al. | Mar 2003 | A1 |
20030139687 | Abreu | Jul 2003 | A1 |
20030144584 | Mendelson | Jul 2003 | A1 |
20030220548 | Schmitt | Nov 2003 | A1 |
20030220576 | Diab | Nov 2003 | A1 |
20040010188 | Wasserman | Jan 2004 | A1 |
20040054270 | Pewzner et al. | Mar 2004 | A1 |
20040087846 | Wasserman | May 2004 | A1 |
20040107065 | Al-Ali | Jun 2004 | A1 |
20040127779 | Steuer et al. | Jul 2004 | A1 |
20040171920 | Mannheimer et al. | Sep 2004 | A1 |
20040172222 | Simpson | Sep 2004 | A1 |
20040176670 | Takamura et al. | Sep 2004 | A1 |
20040176671 | Fine et al. | Sep 2004 | A1 |
20040230106 | Schmitt et al. | Nov 2004 | A1 |
20050080323 | Kato | Apr 2005 | A1 |
20050101850 | Parker | May 2005 | A1 |
20050113651 | Wood et al. | May 2005 | A1 |
20050113656 | Chance | May 2005 | A1 |
20050168722 | Forstner et al. | Aug 2005 | A1 |
20050177034 | Beaumont | Aug 2005 | A1 |
20050192488 | Bryenton et al. | Sep 2005 | A1 |
20050203357 | Debreczeny et al. | Sep 2005 | A1 |
20050228248 | Dietiker | Oct 2005 | A1 |
20050267346 | Faber et al. | Dec 2005 | A1 |
20050267402 | Stewart et al. | Dec 2005 | A1 |
20050283059 | Iyer et al. | Dec 2005 | A1 |
20060009688 | Lamego et al. | Jan 2006 | A1 |
20060015021 | Cheng | Jan 2006 | A1 |
20060020181 | Schmitt | Jan 2006 | A1 |
20060030763 | Mannheimer et al. | Feb 2006 | A1 |
20060052680 | Diab | Mar 2006 | A1 |
20060058683 | Chance | Mar 2006 | A1 |
20060064024 | Schnall | Mar 2006 | A1 |
20060195028 | Hannula et al. | Aug 2006 | A1 |
20060224058 | Mannheimer | Oct 2006 | A1 |
20060247501 | Ali | Nov 2006 | A1 |
20060258921 | Addison et al. | Nov 2006 | A1 |
20060258926 | Ali et al. | Nov 2006 | A1 |
20070032714 | Mannheimer | Feb 2007 | A1 |
20070109115 | Kiana et al. | May 2007 | A1 |
20080183058 | Mannheimer | Jul 2008 | A1 |
Number | Date | Country |
---|---|---|
2536290 | Aug 2004 | CA |
2237544 | Sep 1990 | JP |
8256996 | Oct 1996 | JP |
WO 2004038669 | May 2004 | WO |
WO 2005020176 | Mar 2005 | WO |
Entry |
---|
Barnum, P.T., et al.; “Novel Pulse Oximetry Technology Capable of Reliable Bradycardia Monitoring in the Neonate,” Respiratory Care, vol. 42, No. 1, p. 1072 (Nov. 1997). |
Manley, Geoffrey t., et al., Cerebral Oxygenation during Hemorrhagic Shock: Perils of Hyperventilation and the Therapeutic Potential of Hypoventilation, Jun. 2000, The Journal of Trauma: Injury, Infection, and Critical Care, Lippincott Williams & Wilkins, Inc., 0022-5282/00/4806-1025. |
Belal, Suliman Yousef, et al.; “A fuzzy system for detecting distorted plethysmogram pulses in neonates and paediatric patients,” Physiol. Meas., vol. 22, pp. 397-412 (2001). |
Lutter, Norbert O., et al.; “False Alarm Rates of Three Third-Generation Pulse Oximeters in PACU, ICU and IABP Patients,” Anesth Analg, vol. 94, pp. S69-S75 (2002). |
Number | Date | Country | |
---|---|---|---|
20090221887 A1 | Sep 2009 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 11241513 | Sep 2005 | US |
Child | 12276188 | US |